A Phase II Study of Pazopanib (GW786034, NSC# 737754) in Children, Adolescents and Young Adults with Refractory Solid Tumors
A Phase II Study of Pazopanib (GW786034, NSC# 737754) inChildren, Adolescents and Young Adults with Refractory SolidTumors
A Phase II Study of Pazopanib (GW786034, NSC# 737754) in Children, Adolescents and Young Adults with Refractory Solid Tumors
100 项与 Novartis Pharma Services AG 相关的临床结果
0 项与 Novartis Pharma Services AG 相关的专利(医药)
100 项与 Novartis Pharma Services AG 相关的药物交易
100 项与 Novartis Pharma Services AG 相关的转化医学